Magnetic Targeting of Human Olfactory Mucosa Stem Cells Following Intranasal Administration: a Novel Approach to Parkinson’s Disease Treatment

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Molecular Neurobiology

• Publication date

  2021-04-15

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1007/s12035-021-02392-zPMID 33860441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease

  2021cited by this paper
• Magnetic targeted delivery of the SPIONs-labeled mesenchymal stem cells derived from human Wharton's jelly in Alzheimer's rat models.

  2020cited by this paper
• Differential gene expression and stereological analyses of the cerebellum following methamphetamine exposure

  2020cited by this paper
• Iron oxide nanoparticles promote the migration of mesenchymal stem cells to injury sites

  2019cited by this paper
• Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.

  2019cited by this paper
• CompAct

  2019cited by this paper
• Differentiation of human olfactory system‐derived stem cells into dopaminergic neuron‐like cells: A comparison between olfactory bulb and mucosa as two sources of stem cells

  2019cited by this paper
• Olfactory mucosa stem cells: An available candidate for the treatment of the Parkinson's disease

  2019cited by this paper
• Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson’s disease therapy

  2019cited by this paper
• Alginate Nanoparticles for Drug Delivery and Targeting.

  2019cited by this paper
• Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs.

  2019cited by this paper
• Therapy With Mesenchymal Stem Cells in Parkinson Disease: History and Perspectives

  2018cited by this paper
• Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

  2018cited by this paper
• The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System

  2018cited by this paper
• Mesenchymal stem cell therapy in Parkinson's disease animal models.

  2017cited by this paper
• Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.

  2017cited by this paper
• Magnetic Enhancement of Stem Cell–Targeted Delivery into the Brain Following MR-Guided Focused Ultrasound for Opening the Blood–Brain Barrier

  2017cited by this paper
• SPIONs for cell labelling and tracking using MRI: magnetite or maghemite?

  2017cited by this paper
• Biological effects of iron oxide‐protamine sulfate complex on mesenchymal stem cells and its relaxometry based labeling optimization for cellular MRI

  2017cited by this paper
• Magnetic targeting as a strategy to enhance therapeutic effects of mesenchymal stromal cells

  2017cited by this paper
• Superparamagnetic iron oxide nanoparticles for direct labeling of stem cells and in vivo MRI tracking.

  2016cited by this paper
• A New Method for Preparing Mesenchymal Stem Cells and Labeling with Ferumoxytol for Cell Tracking by MRI

  2016cited by this paper
• Behaviour of adipose-derived canine mesenchymal stem cells after superparamagnetic iron oxide nanoparticles labelling for magnetic resonance imaging

  2016cited by this paper
• Secretome of Olfactory Mucosa Mesenchymal Stem Cell, a Multiple Potential Stem Cell

  2016cited by this paper
• Chitosan (or alginate)-coated iron oxide nanoparticles: A comparative study

  2015cited by this paper
• Olfactory ecto-mesenchymal stem cells possess immunoregulatory function and suppress autoimmune arthritis

  2015cited by this paper
• Advanced cell therapies: targeting, tracking and actuation of cells with magnetic particles.

  2015cited by this paper
• Magnetic targeting of human mesenchymal stem cells with internalized superparamagnetic iron oxide nanoparticles.

  2013cited by this paper
• Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat.

  2013cited by this paper
• The secretome of mesenchymal stem cells: potential implications for neuroregeneration.

  2013cited by this paper
• Rapid spectrophotometric technique for quantifying iron in cells labeled with superparamagnetic iron oxide nanoparticles: potential translation to the clinic.

  2013cited by this paper
• Delayed Intranasal Delivery of Hypoxic-Preconditioned Bone Marrow Mesenchymal Stem Cells Enhanced Cell Homing and Therapeutic Benefits after Ischemic Stroke in Mice

  2013cited by this paper
• Stem Cell Challenges in the Treatment of Neurodegenerative Disease

  2012cited by this paper
• Intranasal Treatment of Central Nervous System Dysfunction in Humans

  2012cited by this paper
• Stem cell therapy in neurodegenerative diseases

  2012cited by this paper
• Synthesis and stabilisation of superparamagnetic iron oxide nanoparticle dispersions

  2011cited by this paper
• Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging.

  2011cited by this paper
• Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

  2011influential reference
• Self-Assembling Nanocomplexes by combining Ferumoxytol, Heparin And Protamine For Cell Tracking by MRI

  2011cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• The Human Nose Harbors a Niche of Olfactory Ectomesenchymal Stem Cells Displaying Neurogenic and Osteogenic Properties

  2010cited by this paper
• Magnetic nanoparticles as both imaging probes and therapeutic agents.

  2010cited by this paper
• Intranasal delivery of cells to the brain.

  2009cited by this paper
• Iron oxide nanoparticle platform for biomedical applications.

  2009cited by this paper
• Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing

  2007cited by this paper
• Magnetic and fluorescent multifunctional chitosan nanoparticles as a smart drug delivery system

  2007cited by this paper
• Properties of porcine and recombinant human collagen matrices for optically clear tissue engineering applications.

  2006cited by this paper
• Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.

  2003cited by this paper
• Thyrotropin‐Releasing Hormone Receptor Binding Sites: Autoradiographic Distribution in the Rat and Guinea Pig Brain

  1985cited by this paper

• MicroRNAs in Parkinson's disease: From pathogenesis to diagnostics and therapeutic strategies.

  2025cites this paper
• Optimizations of Placenta Extracellular Matrix‐Loaded Silk Fibroin/Alginate 3D‐Printed Scaffolds Structurally and Functionally for Bone Tissue Engineering

  2025cites this paper
• Nasal Mucosa-Derived Ectodermal Mesenchymal Stem Cells for Parkinson's Therapy: From Developmental Insights to Application.

  2025cites this paper
• The Application of Magnetic Particles for Cell Targeting in Preclinical Animal Models: A Systematic Review

  2025cites this paper
• Novel therapeutic hydrogel of amniotic membrane extract/oxidase carboxymethyl cellulose in wound healing: Synthesis, physical and biological characterization, and in vivo examinations.

  2025cites this paper
• Investigating nanoparticle's utilization in stem cell therapy for neurological disorders.

  2025cites this paper
• Bilateral Crosslinking with Glutaraldehyde and 1-Ethyl-3-(3-Dimethylaminopropyl) Carbodiimide: An Optimization Strategy for the Application of Decellularized Human Amniotic Membrane in Tissue Engineering

  2024cites this paper
• Intranasal delivery of human Wharton’s jelly-derived mesenchymal stem cells alleviates Aβ-induced Alzheimer’s symptoms in rat models by regulating neurotrophic and apoptotic factors

  2024cites this paper
• Intranasal delivery of imaging agents to the brain

  2024cites this paper
• Microfluidic 3D cell culture: potential application of collagen hydrogels with an optimal dose of bioactive glasses

  2024cites this paper
• 3D morphometry of endothelial cells angiogenesis in an extracellular matrix composite hydrogel

  2024cites this paper
• Improvement of spatial learning and memory deficits by intranasal administration of human olfactory ecto-mesenchymal stem cells in an Alzheimer's disease rat model.

  2024cites this paper
• Research progress on intranasal treatment for Parkinson's disease

  2024cites this paper
• Macrophage cell morphology‐imprinted substrates can modulate mesenchymal stem cell behaviors and macrophage M1/M2 polarization for wound healing applications

  2023cites this paper
• Directly coaxial bioprinting of 3D vascularized tissue using novel bioink based on decellularized human amniotic membrane.

  2023cites this paper
• Recent advances of superparamagnetic iron oxide nanoparticles and its applications in neuroscience under external magnetic field

  2023cites this paper
• Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease.

  2023cites this paper
• Evaluation of an antibacterial peptide‐loaded amniotic membrane/silk fibroin electrospun nanofiber in wound healing

  2023cites this paper
• 3D-printed placental-derived bioinks for skin tissue regeneration with improved angiogenesis and wound healing properties

  2023cites this paper
• Intranasal delivery of stem cells labeled by nanoparticles in neurodegenerative disorders: Challenges and opportunities.

  2023cites this paper
• Engineering advanced nanomedicines against central nervous system diseases

  2023cites this paper
• Three-dimensional-printed polycaprolactone/polypyrrole conducting scaffolds for differentiation of human olfactory ecto-mesenchymal stem cells into Schwann cell-like phenotypes and promotion of neurite outgrowth.

  2022cites this paper
• 3D‐printed PLA/Gel hybrid in liver tissue engineering: Effects of architecture on biological functions

  2022cites this paper
• Photobiomodulation Therapy and Cell Therapy Improved Parkinson's Diseases by Neuro-regeneration and Tremor Inhibition.

  2022cites this paper
• Innovative nanotechnology tools for the functional control and tracking of human stem cells

  2022cites this paper
• A TGF‐α and TGF‐β1 Poloxamer‐based micelle/hydrogel composite: A promising novel candidate for the treatment of anosmia

  2022cites this paper
• Improvement of synaptic plasticity by nanoparticles and the related mechanisms: Applications and prospects.

  2022cites this paper
• New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery

  2022cites this paper
• An additive manufacturing-based 3D printed poly ɛ-caprolactone/alginate sulfate/extracellular matrix construct for nasal cartilage regeneration.

  2022cites this paper
• Human Olfactory Ecto-mesenchymal Stem Cells Displaying Schwann-cell-like Phenotypes and Promoting Neurite Outgrowth in Vitro

  2021cites this paper